Direxion Daily S&P Biotech Bull 3X ETF
LABU
18 hedge funds and large institutions have $26M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
29% more funds holding
Funds holding: 14 → 18 (+4)
12% more capital invested
Capital invested by funds: $23.2M → $26M (+$2.8M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.04% less ownership
Funds ownership: 0.32% → 0.29% (-0.04%)
41% less call options, than puts
Call options by funds: $51.8M | Put options by funds: $87.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wolverine Trading
Chicago,
Illinois
|
+$3.07M |
| 2 |
Jane Street
New York
|
+$1.69M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.39M |
| 4 |
HJMC
Hellman Jordan Management Company
Quincy,
Massachusetts
|
+$982K |
| 5 |
VF
Virtu Financial
New York
|
+$407K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.69M |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$827K |
| 3 |
SAM
SP Asset Management
Cupertino,
California
|
-$474K |
| 4 |
Morgan Stanley
New York
|
-$401K |
| 5 |
TCM
Traynor Capital Management
Malvern,
Pennsylvania
|
-$9.82K |
LABU Hedge Fund Activity: Q3 2018 in Review
18 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q3 2018, worth a combined $26M — up 12% from $23.2M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new LABU positions and 3 closed out — a net gain of 4 holders — while 7 added to existing stakes and 3 trimmed.
The largest buyer was Wolverine Trading, opening a new position worth an estimated $3.07M. The largest seller was Tower Research Capital (TRC), cutting an estimated $3.69M.
- 18 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q3 2018, up from 14 in Q2 2018.
- Funds reported $26M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q3 2018, up 12% quarter-over-quarter.
- 7 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q3 2018 and 3 closed out, a net change of +4 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q3 2018 was Wolverine Trading, an estimated $3.07M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q3 2018 was Tower Research Capital (TRC), an estimated $3.69M sold.
Based on aggregated 13F filings for Q3 2018.